Patients Are Loving The New My Portal Dignity Health Features

bejo

6909

Share

Patients Are Loving The New My Portal Dignity Health Features

参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.

Arizona Dignity Health

Introducing My Portal by Dignity Health: Health at your fingertips ...